Michael Heslinga is a Principal Scientist at Merck, where they lead the design and development of various small molecule formulations. Prior to their role at Merck, they served as a Senior Scientist at Allergan from 2017 to 2020. Michael gained valuable teaching experience as a Graduate Student Instructor at the University of Michigan and worked as a Teaching Assistant at Calvin College. They earned a Master of Science in Chemical Engineering from the University of Michigan and a Bachelor of Science in Engineering with a focus on Chemical Concentration and Physics from Calvin University.
Location
Irvine, United States
This person is not in any offices